Thermo Fisher signed a deal with a Flagship spinout, Waters Corp. made an acquisition and a Newton obesity biotech raised ...

The start-up aims to use AI to drastically reduce the time and money it takes to develop new drugs. View on euronews ...

Celestica could be a hidden gem in AI hardware and supply chains, which enjoy strong growth, low valuation, and reduced risk.

Strategic acquisition marks significant step to establish pan-European footprint and deepens expertise in oncology and early-phase biotech clinical trials.